论文部分内容阅读
rhG-CSF 在一些造血疾病的治疗中已取得了升高白细胞作用.对中粒细胞(N)的产生有刺激作用.本文报告20例儿童“再障”患者应用重组人粒细胞克隆刺激因子(rhG-CSF)治疗的结果.其中男9例,女11例;年龄1～7岁;急性者8例,慢性者12例;继发性(急性肝炎引起)2例;原发性18例;从初诊到首次治疗间期1～240周。除5例外,其余曾接受大剂量甲基强的松龙、抗淋巴细胞球蛋白、睾酮及环孢霉素A 等治疗.rhG-CSF 用法:小剂量400μg/m~2/
rhG-CSF in some hematopoietic diseases have been achieved by the treatment of leukopenia effect on the production of neutrophils (N) have a stimulating effect.In this paper, 20 cases of children with “aplastic anemia” patients using recombinant human granulocyte-stimulating factor rhG-CSF), including 9 males and 11 females, aged from 1 to 7 years, 8 acute and 12 chronic, 2 secondary to acute hepatitis, 18 primary, From first visit to the first treatment interval of 1 to 240 weeks. In addition to 5 cases, the other had received high doses of methylprednisolone, anti-lymphocyte globulin, testosterone and cyclosporin A treatment.rhG-CSF usage: low-dose 400μg / m ~ 2 /